In addition to developing the Rome Criteria for diagnosing Functional GI Disorders (FGIDs), the Rome Foundation appoints working teams that address other complex issues in the field. In choosing team members, the Board has selected senior-level members internationally who are directly involved in and who have published in the topic areas chosen by the Board. The purpose of these working team committees is to develop a summary of the research and literature to date and then offer guidelines or recommendations to help advance future research. The teams would then develop a manuscript to be published in a peer-reviewed journal.
Asian-Rome Working Team
Kok Ann Gwee MD, PhD, Chair
Singapore
William E. Whitehead, PhD, Co-Chair
USA
Food & FGIDs Working Team
William D. Chey, MD, Co-Chair
USA
Jan Tack, MD, PhD, Co-Chair
Belgium
International Liaison Committee
Dan L. Dumitrascu, MD, Chair
Microbiota Working Team
Magnus Simrén, MD, PhD, Chair
Sweden
Giovanni Barbara, MD, Co-Chair
Italy
Multinational Committee
Ami Sperber, MD, MSPH, Chair
Israel
Primary Care Committee
Pali Hungin, MD
United Kingdom
Brain Imaging Working Team
Emeran A. Mayer, MD, Chair
David Geffen School of Medicine at UCLA
Center for Neurovisceral Sciences & Women’s Health
USA
Qasim Aziz, PhD, FRCP (London), Co-Chair
The Wingate Institute
UK
Committee on Outcomes/Endpoints in IBS
Michael Camilleri, MD, Chair
Mayo Medical Center
USA
Rome Severity Committee
Douglas A. Drossman, MD, Chair
UNC Center for Functional GI & Motility Disorders
USA
Lin Chang, MD, Co-Chair
UCLA CNS: Center for Neurovisceral Sciences & Women’s Health
USA
Rome IV Committees
Rome IV: The Functional Gastrointestinal Disorders: Disorders of Gut-Brain Interaction. Through the work of 6 editors, 117 authors from 23 countries on 18 committees, and our administrative staff, Rome IV provides the culmination of a 5-year process with updates in the criteria with 19 chapters that address the organ-based criteria, basic science, physiology, pharmacology & pharmacokinetics, psychosocial aspects, gender, age, society, culture, and the patient’s perspective, design of treatment trials, and development and validation of the Rome IV diagnostic questionnaire.
Herein is a list of the members whose knowledge, experience, and hard work led to this final product.